• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The impact of underlying disease state on outcomes in patients with pyoderma gangrenosum: A national survey.潜在疾病状态对坏疽性脓皮病患者结局的影响:一项全国性调查。
J Am Acad Dermatol. 2018 Oct;79(4):659-663.e2. doi: 10.1016/j.jaad.2018.02.007. Epub 2018 Feb 10.
2
The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.年龄与坏疽性脓皮病临床表现和合并症的关系。
JAMA Dermatol. 2018 Apr 1;154(4):409-413. doi: 10.1001/jamadermatol.2017.5978.
3
Pyoderma gangrenosum: uncommon presentations.坏疽性脓皮病:罕见表现。
Clin Dermatol. 2005 Nov-Dec;23(6):612-20. doi: 10.1016/j.clindermatol.2005.01.014.
4
Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.坏疽性脓皮病:31例患者回顾性队列研究中的临床特征、相关疾病及治疗反应
Int J Dermatol. 2017 Apr;56(4):386-391. doi: 10.1111/ijd.13591.
5
Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.与坏疽性脓皮病相关的疾病谱及其与治疗效果的相关性:化脓性汗腺炎合并症诊断与治疗的新见解
Wound Repair Regen. 2022 May;30(3):338-344. doi: 10.1111/wrr.13014. Epub 2022 Apr 27.
6
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
7
Pyoderma gangrenosum associated with solid organ malignancies.与实体器官恶性肿瘤相关的坏疽性脓皮病。
Int J Dermatol. 2015 Sep;54(9):e351-7. doi: 10.1111/ijd.12796. Epub 2015 Mar 13.
8
Tricenter analysis of cofactors and comorbidity in patients with pyoderma gangrenosum.坏疽性脓皮病患者辅助因子与共病的三中心分析
J Dtsch Dermatol Ges. 2016 Oct;14(10):1023-1030. doi: 10.1111/ddg.12791.
9
Peripheral ulcerative keratitis--an extracutaneous neutrophilic disorder: report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy.周边溃疡性角膜炎——一种皮肤外嗜中性粒细胞疾病:1例类风湿关节炎、脓疱性血管炎、坏疽性脓皮病和Sweet综合征患者对环孢素治疗反应良好的报告。
J Am Acad Dermatol. 1999 Feb;40(2 Pt 2):331-4. doi: 10.1016/s0190-9622(99)70479-2.
10
Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study.英国坏疽性脓皮病的发病率、死亡率和疾病相关性:一项回顾性队列研究。
J Invest Dermatol. 2012 Sep;132(9):2166-70. doi: 10.1038/jid.2012.130. Epub 2012 Apr 26.

引用本文的文献

1
Treatments for Pyoderma Gangrenosum: A Systematic Review and Single-Arm Meta-Analysis of Systemic Therapies.坏疽性脓皮病的治疗:全身治疗的系统评价和单臂荟萃分析
Int Wound J. 2025 Aug;22(8):e70733. doi: 10.1111/iwj.70733.
2
Pyoderma gangrenosum: a 22-year follow-up of patients in a tertiary reference hospital in Brazil.坏疽性脓皮病:巴西一家三级转诊医院患者的22年随访
An Bras Dermatol. 2025 May-Jun;100(3):462-469. doi: 10.1016/j.abd.2024.07.014. Epub 2025 Apr 17.
3
Pyoderma Gangrenosum in a Patient with Crohn's Disease Treated with Adalimumab: A Case-Based Review and Systematic Review of the Current Literature.用阿达木单抗治疗的克罗恩病患者发生坏疽性脓皮病:基于病例的回顾及当前文献的系统评价
Clin Pract. 2025 Mar 11;15(3):57. doi: 10.3390/clinpract15030057.
4
Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Rare Case Involving Mandibular, Elbow, and Pubic Ulcers.炎症性肠病中的坏疽性脓皮病:一例累及下颌、肘部和耻骨溃疡的罕见病例。
J Brown Hosp Med. 2024 Jan 1;3(1):90522. doi: 10.56305/001c.90522. eCollection 2024.
5
Pyoderma gangrenosum.坏疽性脓皮病。
Nat Rev Dis Primers. 2020 Oct 8;6(1):81. doi: 10.1038/s41572-020-0213-x.
6
The great imitator with no diagnostic test: pyoderma gangrenosum.无诊断检测手段的“伟大模仿者”:坏疽性脓皮病。
Int Wound J. 2020 Dec;17(6):1774-1782. doi: 10.1111/iwj.13466. Epub 2020 Aug 11.
7
Unusual case of extracutaneous pyoderma gangrenosum with myelodysplastic syndrome.伴有骨髓增生异常综合征的皮肤外坏疽性脓皮病罕见病例。
Int J Clin Exp Pathol. 2019 Sep 1;12(9):3675-3678. eCollection 2019.
8
Scrotal necrosis and no Fournier's in sight: a rare case of juvenile gangrenous vasculitis.阴囊坏死且未见福尼埃坏疽:一例罕见的青少年坏疽性血管炎病例
BMJ Case Rep. 2019 Feb 21;12(2):e226530. doi: 10.1136/bcr-2018-226530.

本文引用的文献

1
Association of Dermatology Consultations With Patient Care Outcomes in Hospitalized Patients With Inflammatory Skin Diseases.皮肤科会诊与住院炎症性皮肤病患者的患者护理结局之间的关联
JAMA Dermatol. 2017 Jun 1;153(6):523-528. doi: 10.1001/jamadermatol.2016.6130.
2
Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.坏疽性脓皮病:31例患者回顾性队列研究中的临床特征、相关疾病及治疗反应
Int J Dermatol. 2017 Apr;56(4):386-391. doi: 10.1111/ijd.13591.
3
Serious infections in hospitalized patients with psoriasis in the United States.美国住院银屑病患者的严重感染。
J Am Acad Dermatol. 2016 Aug;75(2):287-96. doi: 10.1016/j.jaad.2016.04.005. Epub 2016 Jun 17.
4
Pyoderma gangrenosum--a systemic disease?坏疽性脓皮病——一种全身性疾病?
Clin Dermatol. 2015 Sep-Oct;33(5):527-30. doi: 10.1016/j.clindermatol.2015.05.003. Epub 2015 May 27.
5
Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study.英国坏疽性脓皮病的发病率、死亡率和疾病相关性:一项回顾性队列研究。
J Invest Dermatol. 2012 Sep;132(9):2166-70. doi: 10.1038/jid.2012.130. Epub 2012 Apr 26.
6
Etiology and management of pyoderma gangrenosum: a comprehensive review.坏疽性脓皮病的病因和治疗:全面综述。
Am J Clin Dermatol. 2012 Jun 1;13(3):191-211. doi: 10.2165/11595240-000000000-00000.
7
Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients.坏疽性脓皮病:103 例患者的回顾性分析,包括患者特征、合并症和治疗。
Br J Dermatol. 2011 Dec;165(6):1244-50. doi: 10.1111/j.1365-2133.2011.10565.x.
8
Pyoderma gangrenosum: a review and update on new therapies.坏疽性脓皮病:新疗法的综述与更新。
J Am Acad Dermatol. 2010 Apr;62(4):646-54. doi: 10.1016/j.jaad.2009.05.030.
9
Dangerous small B-cell clones.危险的小B细胞克隆
Blood. 2006 Oct 15;108(8):2520-30. doi: 10.1182/blood-2006-03-001164. Epub 2006 Jun 22.
10
Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients.坏疽性脓皮病的治疗建议:基于350多名患者的文献循证综述
J Am Acad Dermatol. 2005 Aug;53(2):273-83. doi: 10.1016/j.jaad.2004.10.006.

潜在疾病状态对坏疽性脓皮病患者结局的影响:一项全国性调查。

The impact of underlying disease state on outcomes in patients with pyoderma gangrenosum: A national survey.

机构信息

Department of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio.

Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio.

出版信息

J Am Acad Dermatol. 2018 Oct;79(4):659-663.e2. doi: 10.1016/j.jaad.2018.02.007. Epub 2018 Feb 10.

DOI:10.1016/j.jaad.2018.02.007
PMID:29438762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6086769/
Abstract

BACKGROUND

Whether the underlying disease affects the outcomes in pyoderma gangrenosum (PG) is unclear.

OBJECTIVES

To determine the impact of comorbid disease associations and concomitant procedural treatments on patient outcomes in hospitalizations of patients with PG.

METHODS

A cross-sectional analysis of the National Inpatient Sample for hospitalizations of patients with PG from the years 2002 to 2011, analyzing in-hospital mortality rate and health care resource utilization.

RESULTS

Inflammatory bowel disease was the most frequent comorbid association, followed by inflammatory arthritis, hematologic malignancies/dyscrasia, and vasculitis. Multivariable modeling showed that vasculitis and hematologic malignancy/dyscrasia, when compared with inflammatory bowel disease, were associated with a 4-fold to 6-fold increased risk of in-hospital mortality and increasing health care resource utilization. Inpatient procedural interventions, including skin grafts, biopsies, and debridement, did not affect mortality and were associated with an increased length of stay.

LIMITATIONS

The database does not account for outpatient follow-up; additionally, there was a low rate of coded comorbid conditions.

CONCLUSIONS

Comprehensive evaluation to determine the underlying comorbidity for patients with PG is important for patient risk stratification.

摘要

背景

潜在疾病是否会影响坏疽性脓皮病(PG)的结局尚不清楚。

目的

确定合并疾病关联和伴随程序治疗对 PG 住院患者的预后的影响。

方法

对 2002 年至 2011 年国家住院患者样本中 PG 住院患者进行横断面分析,分析住院死亡率和医疗资源利用情况。

结果

炎症性肠病是最常见的合并症关联,其次是炎症性关节炎、血液系统恶性肿瘤/血液系统疾病和血管炎。多变量模型显示,与炎症性肠病相比,血管炎和血液系统恶性肿瘤/血液系统疾病与住院死亡率增加 4 倍至 6 倍以及医疗资源利用增加相关。包括皮肤移植、活检和清创术在内的住院程序干预措施并不影响死亡率,反而与住院时间延长有关。

局限性

该数据库未考虑门诊随访;此外,合并症的编码率较低。

结论

全面评估 PG 患者的潜在合并症对于患者的风险分层很重要。